SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-23-029944
Filing Date
2023-04-14
Accepted
2023-04-14 17:00:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea176873-13da2feld_180life.htm SC 13D/A 38063
  Complete submission text file 0001213900-23-029944.txt   39412
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90013 | Film No.: 23821878
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 DURHAM TERRACE LONDON X0 W25PB
Business Address
Feldmann Marc (Filed by) CIK: 0001832327 (see all company filings)

Type: SC 13D/A